NEU neuren pharmaceuticals limited

6.69%

$14.20

Thx DPA. Translated to simple English. “ we are for sale! We...

First 31 Last

Share
Profile

Follow
Taureanbull

3,737 Posts.

8215

14/12/24

17:23

Post #: 77050827
Share

Originally posted by DumbPostAvenger ↑

Here is a transcript.
Highlight is what I think was the key bits of what JP said.
Sounds to me like the strategy is to concentrate of getting Ph3 done. In the meantime, if there's a really good offer that will deliver most of the value of 2591, then they'll be open to it.

Takeaway for me is they'll reject any low ball offers.

"what is the long-term strategy for neuren? do we have a vision to become a big farmer?
oh look you don't have to become a big big farmer um you know what what I've said is the huge value opportunity here is phase three for 2591 rightso the question is how much of that do you want to capture. do you want to capture it all or the majority of it or do you want to capture a small slice of it and let someone else take over now, that's what I've talked about in the past and I've said for us with all the experience we've got now and all the cash that we've got that I think capturing most of the value is the best outcome for shareholders. uh I still believe that now that doesn't necessarily mean you're going to become a big farmer. I mean there's another step beyond that which is commercializing the drug that's a much bigger step you know for us going from phase two trials to a small phase three trial is a pretty small step and we're very confident about our ability to execute that but becoming a commercial company that's going to sell a product is a whole different ball game that would be a complete change to the company and probably a shift to the US to do that so that's not currently our strategy but it is an option in the future if you know if shareholders wanted that option that's an option in the future that you can make during ph three in a decision you can make during ph 3 if you want to so so I think for now you know as I said the strategy is to make as much value as we can at a 2591 for shareholders at the same time delivering it to patients and while we're doing that we're going to be completely open the whole time to discussions with other companies about Partnerships of whatever or if they can deliver the sort of value that we're going to get from that phase three uplift."

Expand

Thx DPA.

Translated to simple English. “ we are for sale! We have no intention of selling cheaply. We can afford to continue alone. However if the bidding opens at $100 per share or $12.5BN AUD my door is open. “

Having 3 PH2 trials under our belt and another 5-9 indications showing the same pre-clinical success as the first 4 indications and money coming in from DAYBUE. Jon want RAETA Plus +++.

Next quarter we should see movement here.

NEU Price at posting: $13.32 Sentiment: None Disclosure: Held
24 Upvote

2 Great analysis

Reply

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

First 31 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $14.20		Change 0.890(6.69%)		Mkt cap ! $1.761B

Open	High	Low	Value	Volume
$13.50	$14.26	$12.96	$9.111M	655.8K

Buyers (Bids)

No.	Vol.	Price($)
1	2000	$14.17

Sellers (Offers)

Price($)	Vol.	No.
$14.23	3278	1

View Market Depth

No.	Vol.	Price($)
1	2000	14.170
2	1626	14.160
1	1000	14.100
2	2963	14.030
3	2000	14.000

Price($)	Vol.	No.
14.230	3278	1
14.250	2027	3
14.260	2920	1
14.270	1191	1
14.300	1163	2

Last trade - 16.15pm 27/06/2025 (20 minute delay)

NEU (ASX) Chart

Thx DPA. Translated to simple English. “ we are for sale! We...

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Thx DPA. Translated to simple English. “ we are for sale! We...

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Australia’s gas crisis is here – and dying coal plants aren’t helping

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News